
4bases Launches InnoGraft: A Game-Changer in Graft Rejection Monitoring
4bases, a Swiss-based leader in innovative genetic diagnostic solutions for Next Generation Sequencing (NGS), proudly announces the launch of InnoGraft — a non-invasive, cost-effective, and highly sensitive